论文部分内容阅读
目的:对行超选择介入栓塞治疗对肝癌合并门静脉癌栓的疗效进行观察。方法:选取重庆市垫江县中医院在2008-2014年所治疗的92例肝癌合并门静脉癌栓患者为观察对象,用放射介入的方法对患者加以诊治。在92例患者中,A组有8例患者采用单纯肝动脉化疗药物灌注,B组有70例患者采用肝动脉碘油栓塞加化疗药物灌注,C组有14例患者采用肝动脉化疗药物灌注加碘油栓塞加明胶海绵颗粒栓塞。结果:C组效果最佳,存活率占86.1%,对肿瘤诊治有效率达78.9%;A组存活率占50.1%,对肿瘤诊治有效率达42.7%;B组存活率占66.9%,对肿瘤诊治有效率占62.8%。结论:为肝癌合并门静脉癌栓患者要选择肝动脉化疗药物灌注加碘油栓塞加明胶海绵颗粒栓塞的治疗方法,可以降低死亡率。
Objective: To observe the curative effect of trans-selective interventional embolization on hepatocellular carcinoma with portal vein tumor thrombus. Methods: Totally 92 cases of hepatocellular carcinoma with portal vein tumor thrombus treated in Dianjiang Hospital of Traditional Chinese Medicine in Chongqing from 2008 to 2014 were selected as the observation subjects, and the patients were treated by radiation intervention. In 92 patients, A group of 8 patients with simple hepatic artery chemotherapy drug infusion, B group of 70 patients with hepatic artery lipiodol embolization plus chemotherapy drug infusion, C group of 14 patients with hepatic artery chemotherapy drug infusion Lipiodol embolization plus gelatin sponge particles embolization. Results: C group had the best effect, the survival rate was 86.1%, the effective rate of tumor diagnosis and treatment was 78.9%; the survival rate of A group was 50.1%, the effective rate of tumor diagnosis and treatment was 42.7%; the survival rate of B group was 66.9% The effective rate of diagnosis and treatment accounted for 62.8%. Conclusion: To treat patients with hepatocellular carcinoma complicated by portal vein tumor thrombus, the treatment of hepatic artery chemotherapeutic drug infusion with iodized oil embolization plus gelatin sponge particle embolism can reduce the mortality rate.